Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self- administration in rhesus monkeys: Rapid assessment of cocaine dose-effect functions

Psychopharmacology

Volumn 148, Issue 1, 2000, Pages 41-51

  Caine, S Barak ^a   Negus, S Stevens ^a   Mello, Nancy K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; D1; D2; Dopamine; Rhesus monkey; Self administration

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; QUINELORANE;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 0033959292     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050023     Document Type: Article

References (55)

1. Bergman J, Rosenzweig-Lipson S (1992) Cocaine-antagonist effects of limited efficacy D1 agonists. NIDA Res Monogr 119:185-189
2. Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
3. Bergman J, Rosenzweig-Lipson S, Spealman RD (1995) Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 273:40-48
4. Blackburn KJ, French PC, Merrills RJ (1967) 5-Hydroxytryptamine uptake by rat brain in vitro. Life Sci 6:1653-1663
5. Caine SB (1998a) Cocaine abuse: hard knocks for the dopamine hypothesis? Nature Neurosci 1:90-92
6. Caine SB (1998b) Neuroanatomical bases of the reinforcing stimulus effects of cocaine. In: Higgins ST, Katz JL (eds) Cocaine abuse: behavior, pharmacology, and clinical applications. Academic Press, San Diego, pp 21-50
7. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-1816
8. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218
9. Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333-347
10. 2-like agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360
11. Carey G, Bergman J (1997) Rapid assessment of cocaine self-administration in rhesus monkeys. NIDA Res Monogr 178:282
12. Coyle JT, Snyder SH (1969) Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 166:889-901
13. Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477
14. Emmett-Oglesby MW, Peltier RL, Depoortere RY, Pickering CL, Hooper ML, Gong YH, Lane JD (1993) Tolerance to self-administration of cocaine in rats: timecourse and dose-response determinants using a multi dose method. Drug Alcohol Depend 32:247-256
15. Gerber GJ, Wise RA (1989) Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav 32:527-531
16. Glowa JR, Wojnicki FHE, Matecka D, Rice KC, Rothman RB (1995) Effects of dopamine reuptake inhibitors on food-and cocaine-maintained responding II: comparisons with other drugs and repeated administrations. Exp Clin Psychopharmacol 3:232-239
17. Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology 125:97-104
18. Haney M, Collins ED, Ward AS, Foltin RW, Fischman M (1999) Effects of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102-110
19. Harris JE, Baldessarini RJ (1973) Uptake of [3H]-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology 12:669-679
20. Jaffe JH (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 522-573
21. Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52
22. Katz JL, Witkin, JM (1992) Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology 109:241-244
23. Kleber H (1995) Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin Neuropharmacol 18:S96-S109
24. Kleven MS, Koek W (1996) Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. J Pharmacol Exp Ther 279:1211-1219
25. Kleven MS, Woolverton WL (1990) Effects of continuous infusions of SCH 23390 on cocaine-or food-maintained behavior in rhesus monkeys. Behav Pharmacol 1:365-373
26. Kleven MS, Woolverton WL (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 31:149-158
27. Koob GF, Caine SB, Parsons L, Markou A, Weiss F (1997) Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 57:513-521
28. 3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology (Berl) 124:306-314
29. Malcolm R, Hutto BR, Phillips JD, Ballenger JC (1991) Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychol 52:39-40
30. Malcolm R, Phillips JD, Brady KT, Roberts JR (1994) A comparison of pergolide and bromocriptine in the initial rehabilitation of cocaine dependence. Am J Addict 31:144-150
31. Mansbach RS, Balster RL (1993) Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Depend 31:183-191
32. Mello NK, Negus SS (1996) Preclinical evaluation of pharmaco-therapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424
33. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334:965-972
34. Nader MA, Mach RH (1996) Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by previous cocaine exposure. Psychopharmacology 125:13-22
35. Nader MA, Grant KA, Davies HM, Mach RH, Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther 280:541-550
36. Negus SS, Mello NK, Lamas X, Mendelson JH (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879-890
37. Negus SS, Mello NK, Portoghese PS, Lin C-E (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282:44-55
38. Negus SS, Brandt MR, Mello, NK (1999) Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 291:60-69
39. NIDA (1998) Epidemiologic trends in drug abuse. NIH Publ. No. 98-4300. NIDA, NIH, Rockville, MD
40. 2 agonists in squirrel monkeys. Psychopharmacology 116:9-18
41. Rothman RB, Glowa JR (1995) A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development: focus on GBR 12909. Mol Neurobiol 10:1-19
42. Self DW, Stein L (1992) The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582:349-352
43. 2-like dopamine receptor agonists. Science 271:1586-1589
44. Sinnott RS, Mach RH, Nader MA (1999) Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend 54:97-110
45. Skjoldager P, Winger G, Woods JH (1993) Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend 33:31-39
46. Spealman RD (1996) Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 278:1128-1137
47. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative-stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953
48. Spealman RD, Bergman J, Rosenzweig-Lipson S (1997) Differential modulation of behavioral effects of cocaine by low-and high-efficacy D1 agonists. Psychopharmacology 133:283-292
49. 2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831
50. Weed MR, Woolverton WL (1995) The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374
51. Winger G (1994) Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav Pharmacol 5:141-152
52. Winger G, Woods JH (1996) Effects of buprenorphine on behavior maintained by heroin and alfentanil in rhesus monkeys. Behav Pharmacol 7:155-159
53. Winger G, Palmer RK, Woods JH (1989) Drug-reinforced responding: rapid determination of dose-response functions. Drug Alcohol Depend 24:135-142
54. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713
55. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678-683